Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
the project or seriously compromise the quality of the research. In addition, if established protocols related to privacy, confidentiality, and safety are not followed, confidentiality of participants sensitive
-
, single-cell analysis capabilities, opportunities to partner with the country's strongest concentration of computational neuroscientists and much more. Fellows also enjoy the institute's extensive portfolio
-
Vancouver Spine Research Program | Department of Orthopaedics | Faculty of Medicine Compensation Range $4,333.86 - $5,155.61 CAD Monthly Posting End Date January 14, 2026 Note: Applications will be accepted
-
, compromise research results, and result in loss of research program funding. Serious errors may result in delay or withdrawal of research papers and reports, loss of credibility for the research lab
-
research staff to meet critical deadlines, compromise research results, and result in loss of research program funding. Serious errors may result in delay or withdrawal of research papers and reports, loss
-
degree (M.D., Ph.D. or equivalent) and must be in a research-oriented postdoctoral training program at an academic, government, or non-profit research institution. Applicants must have more than two years
-
to productively engage with diverse communities. McGill implements an employment equity program and encourages members of designated groups to self-identify. Persons with disabilities who anticipate needing
-
assay for diagnostic purposes. Qualifications: Masters Degree required. Prior knowledge in biotechnology, molecular and computational biology, is an asset. The candidate will be required to quickly work
-
orientations and gender identities, as well as from all qualified candidates with the skills and knowledge to productively engage with diverse communities. McGill implements an employment equity program and
-
, Full Professor for Computer Science at ETH Zurich, Prof. Dr. Heidi Wunderli-Allenspach, Rector at ETH Zurich (2007 to 2012) and former Full Professor for Biopharmacy at ETH Zurich, and Prof. Dr. Josef